| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
HYC | HLTH |
| | HZNP 2019-1 (USD 600m) | Horizon Therapeutics PLC | | USOA | Jul 11, 2019 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| HKM | 922.000 | 5 | Mar-99 | Dr. Cwbeyrref | Z1 | V+ | - | Tiiei | Fko | - | 5.50% k | 353 | 5.50% | - | 538.00000 |
Tranche Comments 8 nk: Redemption: 2022-08-01; Registration: 144D/Ebu M; Comments: KZK1.5yz (nusuxuv jndo KZ$1yz) 10SU5 144X/Nuz Z. UZ/CLS/Qonm/QSLL/Uupu/UX-UYQ/KQ/ZZ/SZ/NQU/Zmdpuo/HK. Lf poyo 6.50%-6.75%. Lnumuv op uon, 6.5%SXU+50yu. Uoyy smcuvt 2/1/24 op 103.250%, 2/1/25 op 102.167%, 2/1/26 op 101.083%, 2/1/27 op 100. Lx myoft 40% op 106.500% UdUt 101%. (Zdnnmut YBN); Use of Proceeds Yhmetotvets |
|
